Anti-Fibrinolytic Drugs - Gabon

Gabon

The market of Anti-Fibrinolytic Drugs market in Gabon is expected to witness significant growth in the coming years.
By 2024, the revenue is projected to reach US$0.67m.
Furthermore, an annual growth rate of 4.12% (CAGR 2024-2029) is anticipated, leading to a market volume of US$0.82m by 2029.
It is worth noting that in terms of global comparison, United States is expected to generate the highest revenue of US$9,858.00m in 2024.
Gabon is experiencing an increased demand for anti-fibrinolytic drugs due to the rise in surgical procedures and cardiovascular diseases.

Key regions: United Kingdom, Brazil, Europe, France, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The Anti-Fibrinolytic Drugs market in Gabon has been showing positive growth in recent years, driven by various factors such as increasing awareness of bleeding disorders, rising healthcare expenditure, and the growing geriatric population.

Customer preferences: Gabon is a country with a high burden of bleeding disorders, including hemophilia and von Willebrand disease. As a result, there is a significant demand for anti-fibrinolytic drugs to manage these conditions. Patients in Gabon prefer medications that are effective, safe, and affordable. They also prefer drugs that are readily available and can be easily administered.

Trends in the market: The anti-fibrinolytic drugs market in Gabon is witnessing a growing trend towards the use of generic drugs. This is due to the high cost of branded drugs, which are often unaffordable for many patients. The government of Gabon has also been promoting the use of generic drugs to reduce healthcare costs. As a result, many pharmaceutical companies are focusing on developing and marketing generic versions of anti-fibrinolytic drugs in Gabon. Another trend in the market is the increasing use of e-commerce platforms to purchase anti-fibrinolytic drugs. This is due to the convenience and ease of access provided by online pharmacies.

Local special circumstances: One of the significant challenges facing the anti-fibrinolytic drugs market in Gabon is the lack of access to healthcare facilities in rural areas. Many patients living in rural areas do not have access to healthcare facilities, making it difficult for them to receive treatment for bleeding disorders. Additionally, there is a shortage of trained healthcare professionals in Gabon, which further limits access to healthcare services. The government of Gabon has been working to address these challenges by investing in healthcare infrastructure and training healthcare professionals.

Underlying macroeconomic factors: The Gabonese economy has been growing steadily in recent years, driven by the oil and gas sector. This has led to an increase in healthcare expenditure, which has contributed to the growth of the anti-fibrinolytic drugs market. Additionally, the growing geriatric population in Gabon has led to an increase in the prevalence of bleeding disorders, further driving the demand for anti-fibrinolytic drugs. However, the Gabonese economy is heavily dependent on the oil and gas sector, which makes it vulnerable to fluctuations in global oil prices. This could potentially impact healthcare spending in the country.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.